Sign in

CIK 0001781174

  • Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
825125532
Phone
+1 617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
  1. 4 Shares withheld for taxes Chief Legal Officer gave up 652 shares (to pay taxes)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Shares withheld for taxes Chief Legal Officer gave up 735 shares (to pay taxes)
  5. 4 Shares withheld for taxes EVP - Business Operations gave up 1,900 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 1,470 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Medical Officer gave up 1,395 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Operating Officer gave up 2,450 shares (to pay taxes)
  9. 4 Shares withheld for taxes President and CEO gave up 239,023 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Legal Officer gave up 2,232 shares (to pay taxes)
  11. 4 Grant or award Chief Legal Officer acquired 3,858 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Grant or award President and CEO acquired 493,994 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale 10% owner sold 16 shares at $12.93 ($207)
  17. 4 Exercise or conversion Chief Financial Officer acquired 9,500 shares (option exercise)
  18. 4 Open-market sale 10% owner sold 2,056 shares at $12.14 ($24,960)
  19. 4 Open-market sale 10% owner sold 5,893 shares at an average $12.29 ($72,412)
  20. 4 Exercise or conversion Chief Operating Officer acquired 9,225 shares (option exercise)

Page 9 of 11 · 206 filings